These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 736795)

  • 1. Growth and genetic stability of 4 temperature sensitive (ts) mutants of respiratory syncytial (RS) virus in newborn ferrets.
    Belshe RB; Richardson LS; Prevar DA; Camargo E; Chanock RM
    Arch Virol; 1978; 58(4):313-21. PubMed ID: 736795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of respiratory syncytial virus infection in infant ferrets.
    Prince GA; Porter DD
    Am J Pathol; 1976 Feb; 82(2):339-52. PubMed ID: 1251889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: II. Genetic analysis of virus recovered during infection.
    Belshe RB; Richardson LS; London WT; Sly DL; Camargo E; Prevar DA; Chanock RM
    J Med Virol; 1978; 3(2):101-10. PubMed ID: 104003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of further defective clones of a temperature sensitive mutant (ts-1) of respiratory syncytial virus.
    Richardson LS; Schnitzer TJ; Belshe RB; Camargo E; Prevar DA; Chanock RM
    Arch Virol; 1977; 54(1-2):53-60. PubMed ID: 889442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants.
    Prince GA; Suffin SC; Prevar DA; Camargo E; Sly DL; London WT; Chanock RM
    Infect Immun; 1979 Dec; 26(3):1009-13. PubMed ID: 118925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of the complementation group B temperature-sensitive mutant of respiratory syncytial virus.
    Belshe RB; Richardson LS; Schnitzer TJ; Prevar DA; Camargo E; Chanock RM
    J Virol; 1977 Oct; 24(1):8-12. PubMed ID: 904033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic stability determinants of temperature sensitive, live attenuated respiratory syncytial virus vaccine candidates.
    Lin YH; Deatly AM; Chen W; Miller LZ; Lerch R; Sidhu MS; Udem SA; Randolph VB
    Virus Res; 2006 Jan; 115(1):9-15. PubMed ID: 16099066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The age dependence of respiratory syncytial virus growth in ferret lung can be shown in organ and monolayer cultures.
    Porter DD; Muck KB; Prince GA
    Clin Immunol Immunopathol; 1980 Mar; 15(3):415-23. PubMed ID: 7371226
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth and genetic stability of the ts-1 mutant of respiratory syncytial virus at restrictive temperatures.
    Schnitzer TJ; Richardson LS; Chanock RM
    J Virol; 1976 Feb; 17(2):431-8. PubMed ID: 943572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.
    Crowe JE; Collins PL; London WT; Chanock RM; Murphy BR
    Vaccine; 1993 Nov; 11(14):1395-404. PubMed ID: 8310760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030ΔSH) at permissive and non-permissive temperatures.
    Schickli JH; Kaur J; Tang RS
    Virus Res; 2012 Oct; 169(1):38-47. PubMed ID: 22771939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus ts mutants and nuclear immunofluorescence.
    Faulkner GP; Shirodaria PV; Follett EA; Pringle CR
    J Virol; 1976 Nov; 20(2):487-500. PubMed ID: 62058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.
    Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR
    Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization.
    Crowe JE; Bui PT; Siber GR; Elkins WR; Chanock RM; Murphy BR
    Vaccine; 1995 Jun; 13(9):847-55. PubMed ID: 7483808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees.
    Crowe JE; Bui PT; Davis AR; Chanock RM; Murphy BR
    Vaccine; 1994 Jul; 12(9):783-90. PubMed ID: 7975856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior of vaccine revertants of temperature-sensitive mutants of influenza virus in ferret tracheal organ culture.
    Mostow SR; Hopkins JA; Wright PF
    Infect Immun; 1979 Oct; 26(1):193-6. PubMed ID: 500202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-sensitive mutants of influenza virus. XIII. Evaluation of influenza A/Hong Kong/68 and A/Udorn/72 ts and wild-type viruses in tracheal organ culture at permissive and restrictive temperatures.
    Mostow SR; Flatauer S; Paler M; Murphy BR
    J Infect Dis; 1977 Jul; 136(1):1-6. PubMed ID: 886200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperature-sensitive mutants of influenza A virus. Transfer of the two ts-1A2 ts lesions present in the Udorn/72-ts-1A2 donor virus to the influenza A/Alaska/6/77 (H3N2) wild type virus.
    Murphy BR; Wood FT; Massicot JG; Chanock RM
    Arch Virol; 1980; 65(2):175-86. PubMed ID: 7425858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus.
    Hsu KH; Crowe JE; Lubeck MD; Davis AR; Hung PP; Chanock RM; Murphy BR
    Vaccine; 1995 Apr; 13(5):509-15. PubMed ID: 7543716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis.
    Crowe JE; Bui PT; London WT; Davis AR; Hung PP; Chanock RM; Murphy BR
    Vaccine; 1994 Jun; 12(8):691-9. PubMed ID: 8091846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.